Sample pages - Gale

00936 CHEMI DAROU INDUSTRIAL COMPANY IRAN
Status: Private Company
00936
CHEMI DAROU INDUSTRIAL COMPANY
Address: PO Box 16575-361, Next to Saipa Co, 3km Mark,
Abali Road, Tehran
International tel: +98 (21) 7733 0291
International fax: +98 (21) 7733 6458
Company email: info@chemidarou.com
Website: www.chemidarou.com
Board of Directors: Ali Jabbari (Managing Director)
PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals,
polyvinyl acetate resins and textile auxiliaries
Ticker Symbol: KIMI1
Stock Exchange: TSE
ISIN: IRO1KIMI0001
Status: Public Company
Date of Establishment: 1965
No of Employees: 350
Financial Information:
20.3.10 20.3.11
IR’000 IR’000
Sales turnover 498,833,000 450,475,000
Profit before tax 143,277,000 134,427,000
Profit after tax 112,370,000 115,478,000
Earnings per share IR936 IR481
Share capital 120,000,000 240,000,000
Shareholders’ equity 333,545,000 370,223,000
00937
CINNAGEN COMPANY
Address: 5th Floor, 56 Azimi St, Phase 1, Shahrak Ekbatan,
Tehran
International tel: +98 (211) 4466 6203
International fax: +98 (211) 4466 4991
Company email: info@cinnagen.com;sales@cinnagen.com
Website: www.cinnagen.com
Management: Dr Haleh Hamedifar (President)
PRINCIPAL ACTIVITIES: Molecular biology and biotechnology
company, producing diagnostic/research reagents including
blood grouping reagents, PCR kits and reagents, HIV kits,
T3 T4 kits, LHRH, molecular biology reagents and CA, PH
and CL diagnostic kits
Status: Private Company
Date of Establishment: 1994
00938
COSAR PHARMACEUTICAL COMPANY
Address: 32, 6th Alley, Ahmad Qasir Street, Abbas Abad
Street, 15147-17811 Tehran
International tel: +98 (211) 8873 7401
International fax: +98 (211) 8873 2664
Telex: 223243 CSPH-IR
Website: www.cosarpharm.com
Board of Directors: Faramarz Shariat (Managing Director)
PRINCIPAL ACTIVITIES: Manufacture and idstribution of pharmaceuticals,
particularly antibiotic finished products such
as Ampicillin, Amoxicillin and Cloxacillin
Major Products: Antibiotics oral forms
Trade Names: Irapen, Iramox, Cloxiran, Co-Amoxiclav, Garlet
Principal Banks: Bank Tejarat
Auditors: Rahbord Argham Co
Ticker Symbol: DKSR1
Stock Exchange: TSE
ISIN: IRO1DKSR0001
Status: Public Company
Date of Establishment: 1975
No of Employees: 230
Financial Information:
20.3.10 20.3.11
IR’000 IR’000
Sales turnover 424,078,000 295,540,000
Profit before tax 64,944,000 45,264,000
Profit after tax 52,200,000 45,264,000
Earnings per share IR387 IR251
Share capital 135,000,000 180,000,000
Shareholders’ equity 230,911,000 220,875,000
120
00939
DAMLORAN PHARMACEUTICAL COMPANY
Address: 7 Parvin Street, West Dr Fatemi Avenue, 14186
Tehran
International tel: +98 (21) 6694 5732; +98 (21) 939 690;
+98 (21) 885 6907
International fax: +98 (662) 6694 5736 (Factory);
+98 (21) 651325
Telex: 212710 DVPL IR
Company email: damloran@damloran.com
Website: www.damloran.com/
Board of Directors: Ahmad Karbasi (Managing Director)
PRINCIPAL ACTIVITIES: Manufacture and distribution of
veterinary pharmaceuticals
Trade Names: Damloran
Ticker Symbol: DAML1
Stock Exchange: TSE
ISIN: IRO1DAML0001
Status: Public Company
Date of Establishment: 1983
No of Employees: 220
Financial Information:
20.3.10 20.3.11
IR’000 IR’000
Sales turnover 300,752,000 367,850,000
Profit before tax 61,988,000 70,110,000
Profit after tax 48,396,000 54,654,000
Earnings per share IR1,367 IR1,544
Share capital 35,400,000 35,400,000
Shareholders’ equity 113,486,000 126,710,000
00940
DAROU PAKHSH (HOLDING) COMPANY
Address: Darou Pakhsh Street, 18km Mark, Tehran-Karaj
Highway, Tehran
International tel: +98 (21) 4498 6815
International fax: +98 (21) 4498 7314
Company email: info@dppharma.com
Website: www.dppharma.ir
Board of Directors: Ahmad Sheybani (Managing Director)
PRINCIPAL ACTIVITIES: Investment holding company with
subsidiaries involved in the manufacture and marketing of
pharmaceuticals
Subsidiary Companies: (100% owned unless stated): Darou
Pakhsh Pharmaceuticals Company; Darou Pakhsh Pharmaceuticals
Manufacturing Company
Ticker Symbol: DARO1
Stock Exchange: TSE
ISIN: IRO1DARO0001
Status: Public Company
No of Employees: 3,420
Financial Information:
20.3.10 20.3.11
IR’000 IR’000
Income 580,950,000 701,416,000
Profit before tax 574,325,000 729,997,000
Profit after tax 573,869,000 727,834,000
Earnings per share IR956 IR1,213
Share capital 600,000,000 600,000,000
Shareholders’ equity 1,349,373,000 1,583,474,000
00941
DAROU PAKHSH PHARMACEUTICALS
COMPANY
Address: Darou Pakhsh Street, 18km Mark, Tehran-Karaj
Highway, Tehran
International tel: +98 (21) 4498 6815
International fax: +98 (21) 4498 7314
Company email: info@dppharma.com
Website: www.dppharma.ir
PRINCIPAL ACTIVITIES: Wholesale of pharmaceuticals
Parent Company: Darou Pakhsh (Holding) Company (00940)
Ticker Symbol: DDPK1
Stock Exchange: TSE
ISIN: IRO1DDPK0001
Status: Public Company
Principal Shareholders: Darou Pakhsh (Holding) Company
No of Employees: 260
Financial Information:
20.3.10 20.3.11
IR’000 IR’000
Sales turnover 266,136,000 280,825,000
Profit before tax 25,525,000 36,521,000
Profit after tax 19,956,000 28,779,000
Earnings per share IR570 IR822
Share capital 35,000,000 35,000,000
Shareholders’ equity 57,981,000 68,860,000
00942
DAROU PAKHSH PHARMACEUTICALS
MANUFACTURING COMPANY
Address: Darou Pakhsh Street, 18km Mark, Tehran-Karaj
Highway, Tehran
International tel: +98 (21) 4498 6815
International fax: +98 (21) 4498 7314
Company email: info@dppharma.com
Website: www.dppharma.ir
PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals
Parent Company: Darou Pakhsh (Holding) Company (00940)
Ticker Symbol: DPAK1
Stock Exchange: TSE
ISIN: IRO1DPAK0001
Status: Public Company
Principal Shareholders: Darou Pakhsh (Holding) Company
Financial Information:
20.3.10 20.3.11
IR’000 IR’000
Sales turnover 1,003,667,000 1,101,409,000
Profit before tax 264,658,000 274,454,000
Profit after tax 200,316,000 213,605,000
Earnings per share IR2,003 IR1,068
Share capital 100,000,000 200,000,000
Shareholders’ equity 389,685,000 433,290,000
00943
DOCTOR ABIDI LABORATORIES COMPANY
Address: 8km Mark, Karaj Special Road Boulevard, Tehran
International tel: +98 (21) 4450 4785
International fax: +98 (21) 4450 4787
Company email: info@abidipharma.com
Website: www.doctor-abidi.com
Board of Directors: M Hasan Baradaran Ghasemi (Managing
Director)
PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals
Ticker Symbol: ABDI1
Stock Exchange: TSE
ISIN: IRO1ABDI0001
Status: Public Company
No of Employees: 250
Financial Information:
20.3.10 20.3.11
IR’000 IR’000
Sales turnover 376,023,000 443,887,000
Profit before tax 121,529,000 102,595,000
Profit after tax 98,894,000 80,810,000
Earnings per share IR1,766 IR1,443
Share capital 56,000,000 56,000,000
Shareholders’ equity 190,291,000 213,901,000
00944
EXIR PHARMACEUTICAL COMPANY
Address: PO Box 14335-379, 22 Rahmati Alley, Vali-e Asr,
Tehran
International tel: +98 (21) 8891 8461
International fax: +98 (21) 8889 9358
Company email: info@exir.co.ir
Website: exir.co.ir
Board of Directors: Gholam Hossain Farzandi (Managing
Director)
PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals
Ticker Symbol: EXIR1
Stock Exchange: TSE
ISIN: IRO1EXIR0001
Status: Public Company
No of Employees: 590